New era of integrated cancer biomarker discovery using reverse-phase protein arrays
- 1 February 2016
- journal article
- review article
- Published by Elsevier BV in Drug Metabolism and Pharmacokinetics
- Vol. 31 (1), 35-45
- https://doi.org/10.1016/j.dmpk.2015.11.009
Abstract
No abstract availableKeywords
This publication has 119 references indexed in Scilit:
- Integrated genomic characterization of endometrial carcinomaNature, 2013
- Comprehensive molecular portraits of human breast tumoursNature, 2012
- Sequential Application of Anticancer Drugs Enhances Cell Death by Rewiring Apoptotic Signaling NetworksCell, 2012
- Inhibition of PI3K/mTOR Leads to Adaptive Resistance in Matrix-Attached Cancer CellsCancer Cell, 2012
- Proteomic Consequences of a Single Gene Mutation in a Colorectal Cancer ModelJournal of Proteome Research, 2011
- Kinome siRNA-phosphoproteomic screen identifies networks regulating AKT signalingOncogene, 2011
- A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell SubpopulationsCell, 2010
- Udp‐glucose dehydrogenase as a novel field‐specific candidate biomarker of prostate cancerInternational Journal of Cancer, 2009
- Next-generation high-density self-assembling functional protein arraysNature Methods, 2008
- Antibody screening database for protein kinetic modelingProteomics, 2007